Discontinuation report SANDOZ GLICLAZIDE MR
Report ID | 224137 |
Drug Identification Number | 02461331 |
Brand name | SANDOZ GLICLAZIDE MR |
Common or Proper name | GLICLAZIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 60MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100MRT BO |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | |
Actual discontinuation date | 2024-04-02 |
Remaining supply date | 2024-04-02 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Long Term Back order |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-04-03 | English | Compare |
v4 | 2024-04-02 | French | Compare |
v3 | 2024-04-02 | English | Compare |
v2 | 2024-04-02 | French | Compare |
v1 | 2024-04-02 | English | Compare |
Showing 1 to 5 of 5